Clinical trial Recruiting at 1 site Interventional Ages 12 to 40

Bone-patellar tendon–bone graft versus patellar tendon graft for ACL reconstruction

Official title: Comparison of Morbidity and Functional Outcomes After Anterior Cruciate Ligament Reconstruction With Bone-Tendon-Bone Graft Versus Patellar Tendon Graft Without Patellar Bone Plug in Competitive Athletes

Run by Universidad de Granada · NCT07475351 · Data updated 2026-11-12

This randomized comparison tests whether a patellar tendon graft without the patellar bone plug reduces donor-site problems and gives similar knee function to the standard bone–patellar tendon–bone graft in athletes undergoing ACL reconstruction.

Quick facts

Study typeInterventional
Ages12 Years to 40 Years
SexAll
Enrollment110 (estimated)
SponsorUniversidad de Granada
Academic / other
Locations1 site (Granada, Granada)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedMarch 2027
Study endsMarch 2028
Registry record updatedMarch 23, 2026
Trial IDNCT07475351 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Active athletes aged 12–40 with an ACL tear within six months, patellar tendon length over 42 mm on MRI, and no prior ligament surgery or major meniscal/chondral damage are the ideal candidates.

Probably not a fit

Patients with prior knee ligament surgery, concomitant multiligament injuries, major meniscal tears (>50%), or significant cartilage damage (Outerbridge > II) are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center randomized surgical comparison enrolling active athletes with recent ACL tears to receive either a standard bone–patellar tendon–bone (BPTB) graft or a patellar tendon graft without the patellar bone plug (BPT) for ACL reconstruction. Participants undergo surgery and a structured follow-up program with assessments at 3, 8, 12, and 24 months to capture complications, donor-site morbidity, clinical measures, and functional outcomes. Key inclusion criteria include age 12–40, injury-to-surgery time under six months, and patellar tendon length >42 mm on MRI; major meniscal or high-grade chondral injuries and prior ligament surgery are excluded. The trial compares incidence of anterior knee pain, kneeling discomfort, sensory changes, reinjury, and objective knee stability between the two graft techniques.

Why it matters

Potential benefit: If successful, the patellar-sparing graft could reduce anterior knee pain and kneeling problems while preserving equivalent knee stability and function.

How similar studies have gone: Smaller prior studies have reported lower rates of anterior knee pain with patellar-sparing techniques compared with BPTB, but randomized high-quality evidence is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Time for injury to surgery of less than six months.
* Active athletes (federated or recreational)
* Patellar tendon length \> 42mm measured by MRI.
* Age between 12 and 40 years old
* Genders eligible for Study: both

Exclusion Criteria:

* Previous surgery or history of ligamentous knee injuries.
* Concomitant knee ligament injury
* Major meniscal injury (more than 50% of the lateral or medial meniscus)
* Chondral injury greater than Outerbridge Grade I-II

Where it's running

  • Health Sciences Faculty, University of Granada
    Granada, Granada, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.